[Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor]
- PMID: 18822969
[Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor]
Abstract
Drug delivery system (DDS) is a novel approach to overcome multidrug resistance (MDR) in tumors nowadays. This work was designed to investigate a new micellar delivery system for in vitro reversal of resistant ovarian tumor cells, based on a nonionic triblock copolymer Pluronic P105 and paclitaxel (PTX). The PTX-loaded polymeric micelles (P105/PTX) were prepared by thin film-hydration methods. Based on the results of single factor experiments, the P105/PTX micelle formulation was optimized by employing the central composite design-response surface methodology. The physico-chemical properties of the P105/PTX micelles were characterized, including micelle size, drug loading coefficient, in vitro release behavior, etc. The cytotoxicity of the P105/PTX micelles was assessed against human ovarian tumor cell line, SKOV-3/PTX, by a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl (MTT) assay. In order to understand the possible mechanism of Pluronic effects in resistant tumor cells, cellular uptake study of micellar PTX or Rhodamine-123 (R-123) was also carried out. The results showed that the micelle size was about 24 nm with drug loading coefficient of 1.1% and PTX concentration of 700 microg x mL(-1). The cumulative release amount of PTX from the P105/PTX micelles was only 45.4% in 6 h (P < 0.05) and 79.6% in 24 h, whereas Taxol injection in 6 h released 95.2% PTX. The IC50 values of the P105/PTX micelles and Taxol injection against SKOV-3/PTX were 1.14 and 5.11 microg x mL(-1), and resistance reversion index (RRI) was 9.65 and 2.15, respectively. The micellar PTX or R-123 exhibited a significant increase in cellular uptake in resistant SKOV-3/PTX cells compared with free PTX or R-123. These results indicated that PTX could effectively be solubilized by Pluronic P105 block copolymers via thin film-hydration process and formulation optimization, producing nano-scale polymeric micelles with sustained release property in vitro. The P105/PTX micelles were effectively able to reverse resistance to PTX in SKOV-3/PTX tumor cells compared with Taxol injection or free PTX solution, and the enhanced cytotoxicity in the resistant SKOV-3/PTX cell was related to the improved cellular uptake of PTX by Pluronic P105 copolymers.
Similar articles
-
Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.Biomaterials. 2012 Jun;33(18):4741-51. doi: 10.1016/j.biomaterials.2012.03.013. Epub 2012 Mar 23. Biomaterials. 2012. PMID: 22445254
-
Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.Int J Pharm. 2007 Jun 7;337(1-2):63-73. doi: 10.1016/j.ijpharm.2006.12.033. Epub 2006 Dec 28. Int J Pharm. 2007. PMID: 17289311
-
Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles.Arch Pharm Res. 2008 Apr;31(4):530-8. doi: 10.1007/s12272-001-1189-2. Epub 2008 May 1. Arch Pharm Res. 2008. PMID: 18449513
-
Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers.Crit Rev Ther Drug Carrier Syst. 2002;19(1):1-72. doi: 10.1615/critrevtherdrugcarriersyst.v19.i1.10. Crit Rev Ther Drug Carrier Syst. 2002. PMID: 12046891 Review.
-
Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations.Adv Drug Deliv Rev. 2002 Feb 21;54(2):191-202. doi: 10.1016/s0169-409x(02)00016-9. Adv Drug Deliv Rev. 2002. PMID: 11897145 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources